YUANBAO INC -ADR (YB) Fundamental Analysis & Valuation
NASDAQ:YB • US9879101064
Current stock price
16.99 USD
-0.32 (-1.85%)
Last:
This YB fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. YB Profitability Analysis
1.1 Basic Checks
- YB had positive earnings in the past year.
1.2 Ratios
- YB has a Return On Assets of 43.78%. This is amongst the best in the industry. YB outperforms 100.00% of its industry peers.
- YB's Return On Equity of 62.30% is amongst the best of the industry. YB outperforms 100.00% of its industry peers.
- Looking at the Return On Invested Capital, with a value of 31.79%, YB belongs to the top of the industry, outperforming 99.32% of the companies in the same industry.
- Measured over the past 3 years, the Average Return On Invested Capital for YB is significantly above the industry average of 9.34%.
- The 3 year average ROIC (17.77%) for YB is below the current ROIC(31.79%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 43.78% | ||
| ROE | 62.3% | ||
| ROIC | 31.79% |
ROA(3y)-15.55%
ROA(5y)N/A
ROE(3y)-30.13%
ROE(5y)N/A
ROIC(3y)17.77%
ROIC(5y)N/A
1.3 Margins
- YB has a Profit Margin of 45.67%. This is amongst the best in the industry. YB outperforms 99.32% of its industry peers.
- Looking at the Operating Margin, with a value of 30.12%, YB belongs to the top of the industry, outperforming 91.89% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 30.12% | ||
| PM (TTM) | 45.67% | ||
| GM | N/A |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. YB Health Analysis
2.1 Basic Checks
- The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so YB is creating value.
- The number of shares outstanding for YB remains at a similar level compared to 1 year ago.
- YB has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
- An Altman-Z score of 5.22 indicates that YB is not in any danger for bankruptcy at the moment.
- YB has a better Altman-Z score (5.22) than 97.97% of its industry peers.
- There is no outstanding debt for YB. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 5.22 |
ROIC/WACC4.22
WACC7.54%
2.3 Liquidity
- YB has a Current Ratio of 3.40. This indicates that YB is financially healthy and has no problem in meeting its short term obligations.
- The Current ratio of YB (3.40) is better than 93.24% of its industry peers.
- YB has a Quick Ratio of 3.40. This indicates that YB is financially healthy and has no problem in meeting its short term obligations.
- With an excellent Quick ratio value of 3.40, YB belongs to the best of the industry, outperforming 93.24% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.4 | ||
| Quick Ratio | 3.4 |
3. YB Growth Analysis
3.1 Past
- The Earnings Per Share has grown by an impressive 231.74% over the past year.
- The Revenue has grown by 60.60% in the past year. This is a very strong growth!
EPS 1Y (TTM)231.74%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%424.2%
Revenue 1Y (TTM)60.6%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%33.59%
3.2 Future
- No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
- No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. YB Valuation Analysis
4.1 Price/Earnings Ratio
- YB is valuated cheaply with a Price/Earnings ratio of 2.68.
- 86.49% of the companies in the same industry are more expensive than YB, based on the Price/Earnings ratio.
- The average S&P500 Price/Earnings ratio is at 24.88. YB is valued rather cheaply when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 2.68 | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | -1.2 |
4.3 Compensation for Growth
- YB has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A
5. YB Dividend Analysis
5.1 Amount
- YB does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
YB Fundamentals: All Metrics, Ratios and Statistics
NASDAQ:YB (3/27/2026, 8:00:03 PM)
16.99
-0.32 (-1.85%)
Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupInsurance
GICS IndustryInsurance
Earnings (Last)12-03 2025-12-03
Earnings (Next)N/A N/A
Inst Owners10.54%
Inst Owner Change-4.59%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap765.91M
Revenue(TTM)4.09B
Net Income(TTM)1.87B
Analysts40
Price TargetN/A
Short Float %1.5%
Short Ratio1.53
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 2.68 | ||
| Fwd PE | N/A | ||
| P/S | 1.3 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 1.77 | ||
| P/tB | 1.81 | ||
| EV/EBITDA | -1.2 |
EPS(TTM)6.33
EY37.26%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS13.12
BVpS9.62
TBVpS9.41
PEG (NY)N/A
PEG (5Y)N/A
Graham Number37.01
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 43.78% | ||
| ROE | 62.3% | ||
| ROCE | 40.24% | ||
| ROIC | 31.79% | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | 30.12% | ||
| PM (TTM) | 45.67% | ||
| GM | N/A | ||
| FCFM | N/A |
ROA(3y)-15.55%
ROA(5y)N/A
ROE(3y)-30.13%
ROE(5y)N/A
ROIC(3y)17.77%
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)22.5%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0.96
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | N/A | ||
| Cap/Sales | N/A | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 3.4 | ||
| Quick Ratio | 3.4 | ||
| Altman-Z | 5.22 |
F-ScoreN/A
WACC7.54%
ROIC/WACC4.22
Cap/Depr(3y)24.38%
Cap/Depr(5y)N/A
Cap/Sales(3y)0.2%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)231.74%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%424.2%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)60.6%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%33.59%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y389.63%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y175.37%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y173.23%
OCF growth 3YN/A
OCF growth 5YN/A
YUANBAO INC -ADR / YB Fundamental Analysis FAQ
What is the fundamental rating for YB stock?
ChartMill assigns a fundamental rating of 5 / 10 to YB.
What is the valuation status for YB stock?
ChartMill assigns a valuation rating of 3 / 10 to YUANBAO INC -ADR (YB). This can be considered as Overvalued.
What is the profitability of YB stock?
YUANBAO INC -ADR (YB) has a profitability rating of 6 / 10.
What is the financial health of YUANBAO INC -ADR (YB) stock?
The financial health rating of YUANBAO INC -ADR (YB) is 9 / 10.